“…The study design of most studies that presented the outcome using either cementless primary or revision stem were single-arm, case series 5,[7][8][9][10][11][12][13][14][15][16][17][18][19][20][21] . Although the mid-term implant survival of both primary (85.0% to 96.2%) 7,10,21 and long stem (86.0% to 97.0%) [13][14][15]17,18 were considered good to excellent, the incidence of common complications including surgical site infection (0% vs. 0-7%) 7,10,12,15,21,22 , periprosthetic joint infection (0.7%-5.2% vs. 0-14%) 7,9,16,19 , intraoperative fracture (0.7-20.2% vs. 0-64%) 7,10,12,23 , greater trochanter fracture (3.3% vs. 6.0-19.5%) 8,13,15 , periprosthetic fracture (1.4%-2.1% vs. 1-5%) 5,7,11,14 , stem subsidence (0% vs. 3-19.5%) 7,13,...…”